LncRNA HOTAIR Contributes to Sorafenib Resistance through Suppressing miR-217 in Hepatic Carcinoma.
Conclusions: Lnc HOTAIR could increase sorafenib resistance in HCC by inhibiting miR-217. Our research attempts to elucidate a more effective treatment and provides novel insight into potential clinical treatment for HCC.
PMID: 32462038 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Tang X, Zhang W, Ye Y, Li H, Cheng L, Zhang M, Zheng S, Yu J Tags: Biomed Res Int Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Research | Study